Cargando…
A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
PURPOSE: The aim of this study was to identify a noninvasive urinary marker for prostate cancer (PCa) diagnosis and to validate the clinical performance of this novel urinary mRNA signature using the droplet digital polymerase chain reaction (ddPCR) approach. MATERIALS AND METHODS: A gene expression...
Autores principales: | Kang, Ho Won, Lee, Hee Youn, Byun, Young Joon, Jeong, Pildu, Yoon, Jin Sun, Kim, Dong Ho, Kim, Won Tae, Kim, Yong-June, Lee, Sang-Cheol, Yun, Seok Joong, Kim, Wun-Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329636/ https://www.ncbi.nlm.nih.gov/pubmed/32665998 http://dx.doi.org/10.4111/icu.2020.61.4.411 |
Ejemplares similares
-
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone
por: Kang, Ho Won, et al.
Publicado: (2022) -
Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone
por: Xu, Bei, et al.
Publicado: (2021) -
For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
por: Kim, Won Tae, et al.
Publicado: (2019) -
Technical Aspects of Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
por: Kim, Myong, et al.
Publicado: (2013) -
Prostate Size Correlates with Fasting Blood Glucose in Non-Diabetic Benign Prostatic Hyperplasia Patients with Normal Testosterone Levels
por: Kim, Won Tae, et al.
Publicado: (2011)